Smoking cessation

Nearly 80% of Doctors Worldwide Mistakenly Believe Nicotine Causes Lung Cancer, Thwarting Efforts to Help One Billion Smokers Quit

Retrieved on: 
Thursday, July 20, 2023
Smoke, COPD, Smoker, Nicotine, Doctor, Lung cancer, Research, Atherosclerosis, Science Publishing Group, Lung, RRC, Foundation for a Smoke-Free World, Patient, Physician, Heated tobacco product, Smoking, Smoking cessation, Tobacco, Nursing, Dietary supplement, Pharmaceutical industry, Health

NEW YORK, July 20, 2023 /PRNewswire/ -- A significant majority of doctors across the globe mistakenly attributes the negative health consequences of smoking to nicotine, directly jeopardizing advancements made in helping smokers quit, a survey funded by a Foundation for a Smoke-Free World grant has found.

Key Points: 
  • On average, nearly 77% of doctors mistakenly believe nicotine causes lung cancer and 78% believe it causes atherosclerosis.
  • Encouragingly, on average, more than 80% of physicians surveyed are at least moderately interested in cessation and tobacco harm reduction training.
  • While an average of 87% of doctors at least moderately agree helping patients quit smoking is a priority, it is troubling that on average 74% mistakenly believe nicotine causes a range of illnesses from lung cancer to COPD.
  • These results raise serious concerns about doctors' ability to equip patients who smoke with the most accurate and effective advice on how to quit.

Astellas and Eko Health Announce Agreement to Incorporate Next Generation Eko CORE 500™ Digital Stethoscope into Z1608, an Innovative Solution Under Development for Heart Failure Patients Built on Welldoc's Proven Digital Therapeutic Platform

Retrieved on: 
Tuesday, July 18, 2023
Heart failure, Single-frequency network, Partnership, Diet, Prevalence, American Heart Association, Food and Drug Administration, Cardiovascular disease, Ageing, ECG, Medicine, Stethoscope, Biomarker, AHA, Patient, Eko, Growth, Entrepreneurship, CORE, Health, FDA, Smoking cessation, Self-management, Food, Caregiver, TSE, Pharmaceutical industry, Medical device, Astellas Pharma

In addition, educational content specifically focused on heart failure will be provided by the American Heart Association (AHA) and included in Z1608.

Key Points: 
  • In addition, educational content specifically focused on heart failure will be provided by the American Heart Association (AHA) and included in Z1608.
  • AHA educational content helps individuals, families and caregivers develop lifestyle plans that focus on key factors that impact heart health.
  • There is a high unmet medical need for a noninvasive, connected, portable, and user-friendly digital solution for supporting patients living with heart failure.
  • "Caring for heart failure patients at home requires the ability to precisely measure patient data," said Connor Landgraf, Co-founder and CEO of Eko Health.

How preventive healthcare could save the NHS – lessons from Finland, Japan and Singapore

Retrieved on: 
Wednesday, July 5, 2023
Smoker, Diabetes, Health education, Population, No Net Cost Tobacco Act of 1982, Cardiovascular disease, Health, Cancer, Type 2 diabetes, Tobacco, Risk, Government, Dialysis, School, Metabolic syndrome, Conditional sentence, Efficiency, NHS, Death, Smoking cessation, Health insurance, Pharmaceutical industry, Nursing

If it’s true that an ounce of prevention is worth a pound of cure, preventive healthcare might really save the embattled NHS – now celebrating its 75th anniversary.

Key Points: 
  • If it’s true that an ounce of prevention is worth a pound of cure, preventive healthcare might really save the embattled NHS – now celebrating its 75th anniversary.
  • By promoting healthy lifestyles, early disease detection and timely treatment, the NHS could reduce chronic diseases such as type 2 diabetes, heart disease and cancer.

How?

    • Finland, meanwhile, has one of the lowest rates of cardiovascular disease in Europe, which has been attributed to the country’s comprehensive preventive healthcare initiatives.
    • The number of smokers among Finnish adults has decreased significantly over the past few decades, thanks to government policies that discourage smoking.
    • It also has one of the lowest death rates from cardiovascular diseases in the world.

How much?

    • In the three countries mentioned, there have been very few studies on the economic impact of their preventive healthcare programmes.
    • In Finland, there is good evidence of the effectiveness of the Tobacco Act and cancer screening programmes on health, but the impact on healthcare expenditure is unclear.
    • In Singapore, the government frequently holds question-and-answer sessions on the costs of preventive healthcare and the impact of these programmes.

Measure, measure, measure


    Maybe there’s something more the UK can learn from Japan, Finland and Singapore: if you’re going to invest in prevention, you need comprehensive measures of their effectiveness and efficiency. So what should the UK measure? Assuming the goal of such a programme is to help people feel better while reducing NHS costs, the following would be useful things to track.
    And, most importantly, this information should be collected at the patient level to better measure the effects and to understand engagement with the programmes. Because an ounce of prevention is worth a pound of cure only if it’s true for each of us.

McKesson Unveils New Private Brand of Over-the-Counter Pharmacy Products

Retrieved on: 
Thursday, June 22, 2023
Cosmetics, Retail, Other Health, Pharmaceutical, Women, Seniors, Convenience Store, Discount, Variety, Parenting, Men, Supermarket, Specialty, Family, Biotechnology, Consumer, Health, Sunmark Corporation, Allergy, Digestion, Immunity, Multimedia, Pain, Vitamin, Pharmacist, Consumer Healthcare Products Association, Community, CHPA, Patient, Health Mart, OTC, Smoking cessation, Foster, Caregiver, Pharmaceutical industry, McKesson Corporation

McKesson, a diversified healthcare services company, today announced the launch of Foster & Thrive™, a curated private brand of over-the-counter (OTC) health and wellness products.

Key Points: 
  • McKesson, a diversified healthcare services company, today announced the launch of Foster & Thrive™, a curated private brand of over-the-counter (OTC) health and wellness products.
  • Launching Foster & Thrive unifies the company’s private brand portfolio—consolidating Health Mart® and Sunmark® branded OTC products—to offer expanded availability through increased production volumes and efficiencies that will help meet evolving patient needs and growing demand.
  • “With nearly 200 years of supply chain excellence, McKesson is uniquely positioned to meet this growing demand for private label products that pharmacists, patients and caregivers can depend on,” said Peter Koo, vice president, general manager, Pharmacy & Healthcare Solutions, McKesson.
  • “Foster & Thrive offers pharmacists and their customers selectively sourced products that meet the quality standards of a healthcare leader.

Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease

Retrieved on: 
Tuesday, June 13, 2023
Health, Technology, Health Technology, Research, Artificial Intelligence, Science, Cardiology, DNA, Radiation, Methylation, Diabetes, Single-nucleotide polymorphism, Moyamoya disease, Coronary artery disease, Kidney, A1C, Cardio, Risk, Smoke, Gene, Lipid metabolism, DNA methylation, Smoking cessation, Death, Smoking, CHD, PCR, Glycated hemoglobin, Pharmaceutical industry, Medical imaging

The study titled "The Reversion of the Epigenetic Signature of Coronary Heart Disease in Response to Smoking Cessation" sheds light on the potential of reversing epigenetic changes associated with coronary heart disease (CHD) through smoking cessation.

Key Points: 
  • The study titled "The Reversion of the Epigenetic Signature of Coronary Heart Disease in Response to Smoking Cessation" sheds light on the potential of reversing epigenetic changes associated with coronary heart disease (CHD) through smoking cessation.
  • This new study represents a breakthrough in understanding the potential for reversing epigenetic changes associated with coronary heart disease.
  • Meesha Dogan, Ph.D., CEO and co-founder of Cardio Diagnostics and one of the study's authors, remarked, "Our research represents a substantial advancement in the field of coronary heart disease management.
  • This groundbreaking research marks a significant advancement in understanding and managing coronary heart disease and showcases the potential of integrating AI-driven diagnostics in precision cardiovascular medicine.

Basic Benefits are History: New Global Survey of HR Leaders Reveals that While Mental Health Crisis Looms, Organizations are Seeing Value of Prioritizing Employee Wellbeing

Retrieved on: 
Thursday, June 8, 2023
Virgin Group, Culture, Word, Social media, Mental health, Reward, Multimedia, Mental, Schuylkill and Susquehanna Navigation Company, DE, Organization, Employment, Pulse, Significance, Fortune 500, MD, Hearing, Homebase, YouGov, System, ROI, Health, Smoking cessation, Engagement, Nursing, Risk management

PROVIDENCE, R.I., June 8, 2023 /PRNewswire/ -- Organizations worldwide are facing a multitude of pressures, from financial headwinds and rising costs to continuing staffing and productivity challenges. Amid this volatile and uncertain business environment, a new global survey from Virgin Pulse found that companies are expanding their commitment to wellbeing initiatives with new strategies to attract and retain talent. The 2023 Global Workplace Wellbeing Survey found that companies who offer health and wellbeing programs are seeing clear ROI and increased employee participation, and that these programs help address their top challenges: company culture and mental health. Virgin Pulse, the leading global digital-first health, wellbeing, and navigation company, is unveiling these insights as part of its celebration of Employee Wellbeing Month. Now in its 15th year, Employee Wellbeing Month aims to bring awareness to the need for physical, mental, emotional, financial, and social wellbeing support.

Key Points: 
  • The 2023 Global Workplace Wellbeing Survey found that companies who offer health and wellbeing programs are seeing clear ROI and increased employee participation, and that these programs help address their top challenges: company culture and mental health.
  • Virgin Pulse, the leading global digital-first health, wellbeing, and navigation company, is unveiling these insights as part of its celebration of Employee Wellbeing Month .
  • Today, more than 70% of executives are confidently seeing the ROI from their employee wellbeing strategies, largely attributed to health outcomes.
  • Globally, top talent and retention priorities are to increase employee engagement and satisfaction, work/life flexibility, and employee health and wellbeing.

Next wave of life expectancy gains is on the horizon, says Swiss Re report

Retrieved on: 
Monday, May 22, 2023
Blood pressure, Insurance, Male, Medicine, Obesity, Life, Health, Cholesterol, COVID-19, Cancer, Longevity, Woman, Intelligence, L&H, Life expectancy, Messenger, Violent crime, Alzheimer's disease, Dementia, Forecasting, Diagnosis, Mortality, Public policy, Smoking cessation, Convenience food, Pharmaceutical industry, OECD, Swiss Re

Paul Murray, Swiss Re's CEO of L&H Reinsurance, explains: "While people continue to dream of life expectancy surpassing 100 years, the gains of the last century are under threat.

Key Points: 
  • Paul Murray, Swiss Re's CEO of L&H Reinsurance, explains: "While people continue to dream of life expectancy surpassing 100 years, the gains of the last century are under threat.
  • Life expectancy improvements typically come in waves following major medical breakthroughs or large-scale social trends, such as smoking cessation.
  • In the twentieth century, pharmaceutical innovations which lowered blood pressure and cholesterol triggered a steep improvement in life expectancy.
  • According to Swiss Re's report, advances in cancer treatments and diagnosis have the highest potential to kickstart life expectancy improvements.

Monarch Private Capital, Meta Housing Corporation Partner to Develop Two Affordable Housing Communities in California Totaling 411 Apartment Units

Retrieved on: 
Wednesday, May 17, 2023
Steps, Exercise, Food, Housing, NAHB, Meta, Education, Farmer, Mentorship, Parenting, Student, Restaurant, National Association of Home Builders, LIHTC, Monarch, GED, National Association, Health, Smoking cessation, ESL, Renewable energy, Hotel, Concord

Monarch partnered with Los Angeles developer Meta Housing Corporation to complete the projects, which will provide a total of 411 apartment units.

Key Points: 
  • Monarch partnered with Los Angeles developer Meta Housing Corporation to complete the projects, which will provide a total of 411 apartment units.
  • “The two communities address California’s critical need for affordable housing, particularly among high inflation and rising consumer prices,” according to Brent Barringer , Partner, Managing Director LIHTC & Renewables at Monarch.
  • Aaron Mandel , Executive Vice President of Meta Housing Corporation, noted, “Research has shown that affordable housing communities have a tremendously positive ripple effect on the neighborhoods in which they are located.
  • For more information on Monarch Private Capital and its ESG-oriented impact investment funds, please contact Brent Barringer by emailing [email protected] .

Fraser Communications Appoints Paul Simon, M.D., M.P.H. as Senior Science Advisor

Retrieved on: 
Thursday, April 20, 2023
Communication, HIV/AIDS, Health impact assessment, Public health, Marketing, Pediatrics, Molina Healthcare, Policy, Evidence-based practice, Eye, Los Angeles County Department of Public Health, Epidemic Intelligence Service, EIS, Woman, Medicine, Quality, Doctor of Philosophy, Science, CDC, UCLA Fielding School of Public Health, Korea Disease Control and Prevention Agency, Massachusetts Department of Public Health, Smoking cessation, Public health surveillance, Information management, Herbal cigarette, Nursing, Epidemiology, Accreditation

LOS ANGELES, April 19, 2023 /PRNewswire/ -- Fraser Communications, one of the leading women owned marketing firms in Southern California, announced the appointment of Dr. Paul Simon as Senior Science Advisor.

Key Points: 
  • LOS ANGELES, April 19, 2023 /PRNewswire/ -- Fraser Communications, one of the leading women owned marketing firms in Southern California, announced the appointment of Dr. Paul Simon as Senior Science Advisor.
  • Simon previously served as Chief Science Officer for the Los Angeles Department of Public Health.
  • In this new role Simon will guide outreach strategy and help the agency develop communications efforts with health-related clients across the agency.
  • In his role as Chief Science Officer for the Los Angeles County Department of Public Health, Simon led the Department's efforts to integrate science into public health practice.

Qnovia, Inc. Announces Former Director of FDA’s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor

Retrieved on: 
Tuesday, April 4, 2023
Medical Devices, Medical Supplies, Other Retail, Tobacco, Biotechnology, Other Health, Health, Pharmaceutical, Retail, CDER, COPD, Smoker, Asthma, Depression, Therapy, Heated tobacco product, Nicotine, Center for Drug Evaluation and Research, Public, Policy, Patient, Pain management, FDA, Smoking, Death, Smoking cessation, Disease, Pharmaceutical industry, Research

Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today Mitch Zeller has joined the company as an advisor to focus on policy and regulatory strategy.

Key Points: 
  • Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today Mitch Zeller has joined the company as an advisor to focus on policy and regulatory strategy.
  • Qnovia’s lead asset, QN-01, is an application to FDA’s Center for Drug Evaluation and Research (CDER), with the potential to be the first prescription inhaled smoking cessation therapy.
  • “I am excited to serve as an advisor to Qnovia at this pivotal stage in the company’s lifecycle,” said Mitch Zeller.
  • He was the Director of FDA’s Center for Tobacco Products from March 2013 to April 2022, where he shaped regulatory policy and participated in intra-agency planning for comprehensive nicotine policy.